• About ICNS
    • Business and Editorial Staff
    • Editorial Advisory Board
    • Terms of Usage and Privacy Policies
  • Advertising
  • Subscribe
  • Contact Us
  • Comments
  • Posts
Innovations in Clinical Neuroscience
  • Home
  • Topics
    • Alzheimer’s Disease
    • Anxiety Disorders
    • Behavioral and Cognitive Neurology
    • Biomarkers
    • Bipolar Disorder
    • Child Adol Mental Disorders
    • Cognition
    • Dementia
    • Devices
    • Drug Development
    • Eating Disorders
    • Epilepsy
    • Genetics
    • Headache
    • Impulse Control Disorders
    • Medical Issues
    • Movement Disorders
    • Multiple Sclerosis
    • Mood Disorders
    • Neuro infections
    • Neuro oncology
    • Neurodegenerative Disease
    • Neurologic Systems and Symptoms
    • Pain
    • Parkinson’s disease
    • Patient Assessment
    • Pervasive Developmental Disorders
    • Primary Care
    • Personality Disorders
    • Posttraumatic stress disorder
    • Practice Management
    • Psychology/psychotherapy
    • Quality of Life
    • Schizophrenia
    • Sleep Disorders
    • Substance Use Disorders
    • Suicidality
    • Pain
    • Psychopharmacology
    • Psychosis
    • Technology
    • Traumatic Brain Injury
    • Trial Methodology
  • Departments
    • Book Reviews
    • Brief Reports
    • Case Reports
    • Case Series
    • Case Studies
    • Commentaries
    • Editor’s Message: Issue Highlights
    • Ethics in Psychiatry
    • Forensic Files
    • Hot Topics in Neuroscience
    • Letters to the Editor
    • The Interface
    • Meymandi at Large
    • The Neuroscience Report
    • Original Research
    • Proceedings
    • Psychotherapy Rounds
    • Research to Practice
    • Retrospective Analyses
    • Reviews
    • Risk Management
    • Supplements
    • Trial Methodology
    • Trend Watch
    • Update on Alzheimer’s
    • Update on Blood Brain Barrier
    • Update on Cognition
  • Author Guidelines
  • Permissions
  • Submit Article
  • Digital Editions
MMC Concussion Tests

Validation of the Russian Version of the Positive and Negative Syndrome Scale (PANSS-Ru) and Normative Data

ICNS Online Editor | October 1, 2018
Email this to someone
email
Print this page
Print
Share on Facebook
Facebook
Share on LinkedIn
Linkedin
Tweet about this on Twitter
Twitter
Pin on Pinterest
Pinterest
Digg this
Digg
Flattr the author
Flattr
Buffer this page
Buffer
Share on Yummly
Yummly
Share on VK
VK
Share on Tumblr
Tumblr
Share on Reddit
Reddit
Share on StumbleUpon
StumbleUpon

Share this article.


The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: normative data, Positive and Negative Syndrome Scale (PANSS), psychometric validation, Russia-Belarus, schizophrenia

Category: Assessment Tools, Drug Development, Original Research, Past Articles, Psychiatry, Scales, Schizophrenia, Trial Methodology

Subscribe

If you enjoyed this article, subscribe to receive more just like it.

Subscribe via RSS Feed

Comments are closed.

« Risk Management: My Patient Suicided, Now What?
Does Vitamin D Deficiency Contribute to Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus? »

Login

  • Lost Password

Follow us

  • Twitter
  • Facebook
  • LinkedIn
  • RSS Feed

e-Editions

Current ICNS e-Edition


CNS Summit 2018 Poster Abstracts


Hot Topics in Multiple Sclerosis

Download the ICNS app

Website Archives

Complete Journal Archives

Innovations in Clinical Neuroscience

  • Home
  • Advertise
  • Contact Us
  • Login
  • Register
  • About the Journal
  • Author Guidelines
  • Terms of Usage and Privacy Policies
  • Reprints & Permissions
© 2019 Innovations in Clinical Neuroscience. All rights reserved.